High-dose lapatinib is tolerable when alternating with capecitabine.

NCDB analysis finds no survival benefit for adjuvant radiotherapy.

Distinguishes who can avoid preoperative chemotherapy.

The move has been met with criticism.

A study of patients undergoing intensity-modulated radiation therapy.

The World Medical Association says even advising or preparing for some of the punishments would constitute a gross violation of medical ethics.

Adding DBT can help identify additional ipsilateral and contralateral tumors.

It didn’t help surgeons predict injuries in this small study.

POCUS can be an adjunct for ED clinicians to improve care.

Benefit limited to patients with node-negative disease.

Meta-analysis supports greater efficacy in T1 vs T2 disease.

Most health care systems in the eastern part of the EU are under financed and under equipped to deal with lung cancer

Proton beams allow targeted delivery of higher doses with less collateral damage.

Calls for less frequent screening draw ire.